208 related articles for article (PubMed ID: 11159969)
1. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
3. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
[TBL] [Abstract][Full Text] [Related]
4. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
Sun Y; Hwang Yi; Nahm MH
Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
[TBL] [Abstract][Full Text] [Related]
5. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Front Immunol; 2020; 11():578019. PubMed ID: 33343566
[TBL] [Abstract][Full Text] [Related]
6. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
[TBL] [Abstract][Full Text] [Related]
7. Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
Alonso de Velasco E; Verheul AF; Veeneman GH; Gomes LJ; van Boom JH; Verhoef J; Snippe H
Vaccine; 1993 Nov; 11(14):1429-36. PubMed ID: 8310762
[TBL] [Abstract][Full Text] [Related]
8. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
9. Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.
Jansen WT; Verheul AF; Veeneman GH; van Boom JH; Snippe H
Vaccine; 2001 Oct; 20(1-2):19-21. PubMed ID: 11567741
[TBL] [Abstract][Full Text] [Related]
10. Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.
Lagergård T; Branefors P
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):371-6. PubMed ID: 6201038
[TBL] [Abstract][Full Text] [Related]
11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
12. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
[TBL] [Abstract][Full Text] [Related]
13. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide.
Csordas FC; Perciani CT; Darrieux M; Gonçalves VM; Cabrera-Crespo J; Takagi M; Sbrogio-Almeida ME; Leite LC; Tanizaki MM
Vaccine; 2008 Jun; 26(23):2925-9. PubMed ID: 18440673
[TBL] [Abstract][Full Text] [Related]
14. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.
Robbins JB; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J
Infect Immun; 1979 Dec; 26(3):1116-22. PubMed ID: 43290
[TBL] [Abstract][Full Text] [Related]
17. Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.
McNeely T; Luo S; Manger W; Herber W; Schofield T; Tan C; Newman K; Sadoff J; Donnelly J; Cross A
Vaccine; 2006 Mar; 24(11):1941-8. PubMed ID: 16307833
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides.
Parameswar AR; Park IH; Saksena R; Kovác P; Nahm MH; Demchenko AV
Chembiochem; 2009 Dec; 10(18):2893-9. PubMed ID: 19856369
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
Snippe H; van Houte AJ; van Dam JE; De Reuver MJ; Jansze M; Willers JM
Infect Immun; 1983 Jun; 40(3):856-61. PubMed ID: 6852923
[TBL] [Abstract][Full Text] [Related]
20. Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups.
Park S; Parameswar AR; Demchenko AV; Nahm MH
Infect Immun; 2009 Aug; 77(8):3374-9. PubMed ID: 19451241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
